The U.S. Department of Justice and 24 states alleged that Abbott illegally marketed Depakote to treat agitation and aggression in the elderly
Abbott unlawfully promoted Depakote as a drug which could control aggression and agitation in elderly dementia patients and to treat
Abbott has pleaded guilty to misbranding Depakote by promoting the drug to control agitation and aggression in elderly dementia patients and to
A study of elderly patients with dementia revealed drug related dose Depakote than for low dose Depakote. For example, when switching from
Impact of Depakote on Agitation and Short-Term Memory in Nursing Home Dementia divalproex sodium for treatment for agitation in dementia at a mean dose
Depakote. Depakote Formulations. JAMA Psychiatry. Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease. Mental Health Clinician. 2024;1(11):14. Dosing of Valproate in an Elderly Population With Dementia: Evaluation of Discontinuations and Dose Reductions.
Depakote. Depakote Formulations. JAMA Psychiatry. Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease. Mental Health Clinician. 2024;1(11):14. Dosing of Valproate in an Elderly Population With Dementia: Evaluation of Discontinuations and Dose Reductions.
Abbott has pleaded guilty to misbranding Depakote by promoting the drug to control agitation and aggression in elderly dementia patients and to
Abbott has pleaded guilty to misbranding Depakote by promoting the drug to control agitation and aggression in elderly dementia patients and to
How many hints does he need to shut up?